Home » Newsletters » BioWorld

BioWorld

Nov. 17, 1993

View Archived Issues

CELEX LICENSES TAXOL PRODUCTION TECHNOLOGY

AURICULIN CUTS NEED FOR DIALYSIS

MIT'S MULLIGAN TO TAKE STINT AT SOMATIX

GENEMEDICINE LICENSES FACTOR IX GENE

FDA TO TIGHTEN RULES AFTER FIAU DISASTER

ALPHA-BETA COMPLETES FOLLOW-ON OFFERING

ARGUS RAISES $10.2 MILLION IN FOLLOW-ON

SOMATOGEN RAISES $44 MILLION

VIAGENE FILES FOR IPO, INKS PACT WITH CHIRON

DRUG PRICES CRITICIZED IN HEARING

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026